Evidence map›Paper›PMID 2000381›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1991

Expression of v-src in a murine T-cell hybridoma results in constitutive T-cell receptor phosphorylation and interleukin 2 production.

J J O'Shea, J D Ashwell, T L Bailey, S L Cross, L E Samelson, R D Klausner

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation.Proceedings of the National Academy of Sciences of the United States of America · 1992
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J J O'SheaBiological Response Modifiers Program, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21701-1201.
J D Ashwell
T L Bailey
S L Cross
L E Samelson
R D Klausner
National Cancer Institute · US

Funding

OPERATIONS AND TECHNICAL SUPPORTN01CO074102 · CO · PROGRAM RESOURCES, INC. · PI COMPTON, THOMAS F · 1987 to 1998
–
NCI NIH HHS N01-CO-74102
6 · The paper itself

Abstract

Ligand binding to the T-cell antigen receptor results in phosphatidylinositol hydrolysis and the resultant activation of protein kinase C, as well as the activation of a receptor-coupled protein-tyrosine kinase. As a model for tyrosine kinase activation in T cells, we used retroviral gene transfer to express the v-src oncogene in an antigen-specific murine T-cell hybridoma. Clones that expressed v-src mRNA demonstrated constitutive tyrosine phosphorylation of several cellular substrates, including the zeta chain of the T-cell receptor, and constitutive interleukin 2 production. Thus, expression of a constitutively active protein-tyrosine kinase such as pp60v-src appears to be sufficient to induce the expression of at least one gene critical to the process of T-cell activation.

Indexed as

Genes, srcAnimalsButyratesButyric AcidGene ExpressionHybridomasInterleukin-2KineticsMicePhosphorylationProtein-Tyrosine KinasesReceptors, Antigen, T-CellRetroviridaeT-LymphocytesTransfectionButyratesButyric AcidInterleukin-2Protein-Tyrosine KinasesReceptors, Antigen, T-Cell

Identifiers

PMID2000381
PMCPMC51100
OpenAlexW1984275497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.